Sree Rayalaseema Hi-Strength Hypo share news, announcements and annual reports
NSE: SRHHYPOLTDBSE: 532842Chemicals & PetrochemicalsSmall Cap
Sree Rayalaseema Hi-Strength Hypo Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2007
Last close ₹504.20up ₹19.00 (3.92%)BSE ₹500.60
Share price at the NSE close on 2 Nov 2026. Previous close ₹485.20.
2 Nov: open ₹489.00, high ₹509.40, low ₹487.45
52-week range of traded prices to 2 Nov 2026
₹382.40Low, 30 Mar 2026₹670.00High, 22 Sep 2026
- Next results date: the board meets on 14 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹865 Cr1,584th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.40
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹12 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 8.29
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.60%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹12 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 11.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 7,325
Sree Rayalaseema Hi-Strength Hypo board meetings
116 filed, newest first. Page 2 of 3.
Nov 2019
Aug 2019
2 Aug · Board meeting
May 2019
30 May · Board meeting
21 May · Board meeting
Mar 2019
21 Mar · Board meeting
Jan 2019
30 Jan · Board meeting
Nov 2018
Aug 2018
6 Aug · Board meeting
May 2018
Jan 2018
Nov 2017
Sep 2017
May 2017
Feb 2017
Nov 2016
Aug 2016
29 Aug · Board meeting
May 2016
Feb 2016
Oct 2015
Sep 2015
Jul 2015
May 2015
Feb 2015
3 Feb · Board meeting
Interalia, to consider and to take on record the un-audited Financial Results fo the quarter/Nine Months period ending December 31, 2014.
Nov 2014
3 Nov · Board meeting
Interalia, to consider and to take on record the Unaudited Financial Results for the second quarter/half year ending September 30, 2014.
Sep 2014
5 Sep · Board meeting
Board of Directors of the Company in their meeting held on August 14, 2014 had decided the following; 1. The Company is providing e-voting facility through CDSL platform and voting period begins on September 22, 2014 and ends on September 24, 2014. 2. The Company is providing postal ballot facility to shareholders who do not have access to e-voting facility and duly completed ballot forms should reach the Scrutinizer Mr. M, Nirmal Kumar Reddy not later than September 24, 2014.
Jul 2014
31 Jul · Board meeting
Intimation regarding date of Board Meeting - Un Audited Financial Results for the First Quarter ending 30.06.2014 - Reg
May 2014
20 May · Board meeting
Inter alia, to consider and to take on record the Audited Financial Results for the year ending March 31, 2014.
Feb 2014
Nov 2013
5 Nov · Board meeting
To consider Unaudited Financial Results for quarter/half year ending 30.09.2013.
Aug 2013
2 Aug · Board meeting
Interalia, to consider and to take on record the Un Audited Financial Results for the first quarter ending 30th June, 2013.
May 2013
9 May · Board meeting
Inter alia, to consider and to take on record the Audited Financial Results for the year ending March 31, 2013.
Feb 2013
4 Feb · Board meeting
Interalia, to consider and to take on record the Un-Audited Financial Results for the quarter/nine months period ending December 31, 2012.
Nov 2012
29 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 28, 2012, inter alia, has decided the following: (1)To allot 7,35,830 convertible share warrants of Rs. 10/- each at a rate of Rs. 55.74 (including premium of Rs 45.74) calculated as per Chapter VII of SEBI (ICDR). Regulations,2009 to M/S Gowri Gopal Hospitals Pvt Ltd, one of the Promoter of the Company under Preferential issue subject to members approval in the ensuing Annual General Meeting to be held on December 28, 2012. These share warrants are to be converted into equity shares within 18 months from the date of allotment of warrants.19 Nov · Board meeting
To consider the allotment of Equity shares under preferential issue to one of the promoters of the Company and fixation of price of the same.6 Nov · Board meeting
Interalia, to consider and to take on record the Un Audited Financial Results for the quarter ending September 30, 2012.
Oct 2012
11 Oct · Board meeting
Inter alia, to consider and to take on record the merged Audited Financial Results: for the year ending March 31, 2012 and fixation of Record Date for allotment of new shares to the shareholders of transferor Companies Viz., SRHHL Industries Ltd. and T G V Pharma Pvt. Ltd. in pursuance to Scheme of Arrangement duly approved by Hon'ble High Court of Andhra Pradesh vide its Order dated August 31, 2012.
Aug 2012
1 Aug · Board meeting
Interalia, to consider and to take on record the Un Audited Financial Results for the first quarter ending June 30, 2012.
May 2012
4 May · Board meeting
Interalia, to consider and to take on record the Un-Audited Financial Results for the last quarter ending March 31, 2012.
Jan 2012
30 Jan · Board meeting
Interalia, to consider and to take on record the Un-Audited Financial Results for the quarter/nine months period ending December 31, 2011.
Oct 2011
26 Oct · Board meeting
Inter alia, to consider and approve the following: 1. Unaudited Financial Results for second quarter / half year ending September 30, 2011. 2. Draft Scheme of Amalgamation among the Company, M/s. SRHHL Industries Ltd. and M/s. TGV Pharma Private Ltd. 3. Allotment of 5,47,370 Equity Shares under Preferential Issue to one of the promoters of the Company M/s Gowri Gopal Hospitals Private Ltd.
Aug 2011
30 Aug · Board meeting
Board of Directors in their meeting held on August 27, 2011 had decided: (1) to allot 5,47,370 Equity shares of Rs.10/- each at a rate of Rs.43.95 (including premium of Rs.33.95) calculated as per Chapter VII of SEBI (ICDR) (Amendment) Regulations, 2011 to M/s Gowri Gopal Hospitals Pvt. Ltd, one of the Promoter of the Company under preferential issue, subject to members approval in the ensuing Annual General Meeting to be held on September 26, 2011.19 Aug · Board meeting
To consider the allotment of Equity shares under preferential issue to one of the promoters of the Company and fixation of price of the same.1 Aug · Board meeting
Interalia, to consider and to take on record the Un Audited Financial Results for the first quarter ending June 30, 2011.
May 2011
23 May · Board meeting
Inter alia, to consider and to take on record the Audited Financial Results for the year ending March 31, 2011.
Mar 2011
11 Mar · Board meeting
For the purpose of declaration of interim dividend for nine months ending December 31, 2010 and to fix record date for ascertaining the eligible shareholders to receive Interim dividend.
Jan 2011
25 Jan · Board meeting
Interalia, to consider and to take on record the Un-Audited Financial Results for the quarter/ nine months ending December 31, 2010.
Oct 2010
20 Oct · Board meeting
Interalia, to consider and to take on record the Un-Audited Financial Results for the quarter ending September 30, 2010.
Aug 2010
17 Aug · Board meeting
To consider the allotment of Equity shares under preferential issue to one of the promoters of the Company and fixation of price of the same.